|
1
|
Richter J, Rudeck S, Kretz AL, Kramer K,
Just S, Henne-Bruns D, Hillenbrand A, Leithauser F, Lemke J and
Knippschild U: Decreased CK1δ expression predicts prolonged
survival in colorectal cancer patients. Tumour Biol. 27:8731–8739.
2016. View Article : Google Scholar
|
|
2
|
Day LW and Velayos F: Colorectal cancer of
the elderly. Curr Treat Options Gastroenterol. 12:269–282. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burada F, Nicoli ER, Ciurea ME, Uscatu DC,
Ioana M and Gheonea DI: Autophagy in colorectal cancer: An
important switch from physiology to pathology. World J Gastrointest
Oncol. 7:271–284. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pibiri F, Kittles RA, Sandler RS, Keku TO,
Kupfer SS, Xicola RM, Llor X and Ellis NA: Genetic variation in
vitamin D-related genes and risk of colorectal cancer in African
Americans. Cancer Causes Control. 25:561–570. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumar K, Brim H, Giardiello F, Smoot DT,
Nouraie M, Lee EL and Ashktorab H: Distinct BRAF (V600E) and KRAS
mutations in high microsatellite instability sporadic colorectal
cancer in African Americans. Clin Cancer Res. 15:1155–1161. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun K, Deng HJ, Lei ST, Dong JQ and Li GX:
miRNA-338-3p suppresses cell growth of human colorectal carcinoma
by targeting smoothened. World J Gastroenterol. 19:2197–2207. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun K, Wang W, Zeng JJ, Wu CT, Lei ST and
Li GX: MicroRNA-221 inhibits CDKN1C/p57 expression in human
colorectal carcinoma. Acta Pharmacol Sin. 32:375–384. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Triantafillidis JK, Vagianos C and
Malgarinos G: Colonoscopy in colorectal cancer screening: Current
aspects. Indian J Surg Oncol. 6:237–250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Malkomes P, Lunger I, Luetticke A,
Oppermann E, Haetscher N, Serve H, Holzer K, Bechstein WO and
Rieger MA: Selective AKT inhibition by MK-2206 represses colorectal
cancer-initiating stem cells. Ann Surg Oncol. 23:2849–2857. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nedrebø BS, Søreide K, Eriksen MT, Kvaløy
JT, Søreide JA and Kørner H: Excess mortality after curative
surgery for colorectal cancer changes over time and differs for
patients with colon versus rectal cancer. Acta Oncol. 52:933–940.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Gestel YR, de Hingh IH, van Herk-Sukel
MP, van Erning FN, Beerepoot LV, Wijsman JH, Slooter GD, Rutten HJ,
Creemers GJ and Lemmens VE: Patterns of metachronous metastases
after curative treatment of colorectal cancer. Cancer Epidemiol.
38:448–454. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsumoto T, Hasegawa S, Matsumoto S,
Horimatsu T, Okoshi K, Yamada M, Kawada K and Sakai Y: Overcoming
the challenges of primary tumor management in patients with
metastatic colorectal cancer unresectable for cure and an
asymptomatic primary tumor. Dis Colon Rectum. 57:679–686. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vissers PA, Thong MS, Pouwer F, den
Oudsten BL, Nieuwenhuijzen GA and van de Poll-Franse LV: The
individual and combined effect of colorectal cancer and diabetes on
health-related quality of life and sexual functioning: Results from
the PROFILES registry. Support Care Cancer. 22:3071–3079. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jeon JY and Meyerhardt JA: Can we change
the past for colorectal cancer patients and how do we move forward?
Cancer. 120:1450–1452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kontou N, Psaltopoulou T, Soupos N,
Polychronopoulos E, Xinopoulos D, Linos A and Panagiotakos DB:
Metabolic syndrome and colorectal cancer: The protective role of
Mediterranean diet-a case-control study. Angiology. 63:390–396.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okugawa Y, Grady WM and Goel A: Epigenetic
alterations in colorectal cancer: Emerging Biomarkers.
Gastroenterology. 149:1204–1225.e12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mundade R, Imperiale TF, Prabhu L, Loehrer
PJ and Lu T: Genetic pathways, prevention, and treatment of
sporadic colorectal cancer. Oncoscience. 1:400–406. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zoratto F, Rossi L, Verrico M, Papa A,
Basso E, Zullo A, Tomao L, Romiti A, Lo Russo G and Tomao S: Focus
on genetic and epigenetic events of colorectal cancer pathogenesis:
Implications for molecular diagnosis. Tumour Biol. 35:6195–6206.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu T, Wu Z, Vervelde L, Rothwell L, Hume
DA and Kaiser P: Functional annotation of the T-cell immunoglobulin
mucin family in birds. Immunology. 148:287–303. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu G, Zheng K, Lu X and Wang J, Chai Y and
Wang J: Association between polymorphisms in the promoter region of
T cell immunoglobulin and mucin domain-3 and myasthenia
gravis-associated thymoma. Oncol Lett. 9:1470–1474. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Angiari S and Constantin G: Regulation of
T cell trafficking by the T cell immunoglobulin and mucin domain 1
glycoprotein. Trends Mol Med. 20:675–684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao
D, Liu Y, Zhu F, Zhang L, Sun W, et al: T cell immunoglobulin- and
mucin-domain-containing molecule-3 (Tim-3) mediates natural killer
cell suppression in chronic hepatitis B. J Hepatol. 52:322–329.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding Q, Yeung M, Camirand G, Zeng Q, Akiba
H, Yagita H, Chalasani G, Sayegh MH, Najafian N and Rothstein DM:
Regulatory B cells are identified by expression of TIM-1 and can be
induced through TIM-1 ligation to promote tolerance in mice. J Clin
Invest. 121:3645–3656. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao S, Brooks CR, Sobel RA and Kuchroo
VK: Tim-1 is essential for induction and maintenance of IL-10 in
regulatory B cells and their regulation of tissue inflammation. J
Immunol. 194:1602–1608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu J, Jiang P and Liu J: Pooled-analysis
of the association between TIM-1 5383_5397 insertion/deletion
polymorphism and asthma susceptibility. Mol Biol Rep. 41:7825–7831.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li M, Ablan SD, Miao C, Zheng YM, Fuller
MS, Rennert PD, Maury W, Johnson MC, Freed EO and Liu SL:
TIM-family proteins inhibit HIV-1 release. Proc Natl Acad Sci USA.
111:E3699–E3707. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chou FC, Kuo CC, Chen HY, Chen HH and
Sytwu HK: DNA demethylation of the TIM-3 promoter is critical for
its stable expression on T cells. Genes Immun. 17:179–186. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai XZ, Huang WY, Qiao Y, Chen Y, Du SY,
Chen D, Yu S, Liu N, Dou LY and Jiang Y: Downregulation of TIM-3
mRNA expression in peripheral blood mononuclear cells from patients
with systemic lupus erythematosus. Braz J Med Biol Res. 48:77–82.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shan NN, Hu Y, Hou M, Gao J, Wang X, Liu X
and Li Y: Decreased Tim-3 and its correlation with Th1 cells in
patients with immune thrombocytopenia. Thromb Res. 133:52–56. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee MJ, Woo MY, Heo YM, Kim JS, Kwon MH,
Kim K and Park S: The inhibition of the T-cell immunoglobulin and
mucin domain 3 (Tim3) pathway enhances the efficacy of tumor
vaccine. Biochem Biophys Res Commun. 402:88–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dardalhon V, Anderson AC, Karman J, Apetoh
L, Chandwaskar R, Lee DH, Cornejo M, Nishi N, Yamauchi A, Quintana
FJ, et al: Tim-3/galectin-9 pathway: Regulation of Th1 immunity
through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol.
185:1383–1392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roth CG, Garner K, Eyck ST, Boyiadzis M,
Kane LP and Craig FE: TIM3 expression by leukemic and non-leukemic
myeloblasts. Cytometry B Clin Cytom. 84:167–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moller-Hackbarth K, Dewitz C, Schweigert
O, Trad A, Garbers C, Rose-John S and Scheller J: A disintegrin and
metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell
immunoglobulin and mucin domain 3 (Tim-3). J Biol Chem.
288:34529–34544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao D, Hou N, Cui M, Liu Y, Liang X,
Zhuang X, Zhang Y, Zhang L, Yin D, Gao L, et al: Increased T cell
immunoglobulin and mucin domain 3 positively correlate with
systemic IL-17 and TNF-α level in the acute phase of ischemic
stroke. J Clin Immunol. 31:719–727. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
M PN: World medical association publishes
the revised declaration of Helsinki. Natl Med J India.
27:562014.PubMed/NCBI
|
|
36
|
Ali R, Toh HC and Chia WK: ASCOLT Trial
Investigators: The utility of Aspirin in Dukes C and High Risk
Dukes B Colorectal cancer-the ASCOLT study: Study protocol for a
randomized controlled trial. Trials. 12:2612011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu H, Krasinskas A and Willis J:
Perspectives on current tumor-node-metastasis (TNM) staging of
cancers of the colon and rectum. Semin Oncol. 38:500–510. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma B, Qu P, Zhang XM, Zhang YF, Hu PZ, Ge
W, Si SY, Huang Y, Li X and Sui YF: Culturing dendritic cells from
the peripheral blood with successive adherence method and observing
the utralmicrostructure of cells. J Mod Oncol. 2007.
|
|
39
|
Forlenza M, Kaiser T, Savelkoul HF and
Wiegertjes GF: The use of real-time quantitative PCR for the
analysis of cytokine mRNA levels. Methods Mol Biol. 820:7–23. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun Y, Shen S, Liu X, Tang H, Wang Z, Yu
Z, Li X and Wu M: MiR-429 inhibits cells growth and invasion and
regulates EMT-related marker genes by targeting Onecut2 in
colorectal carcinoma. Mol Cell Biochem. 390:19–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jayachandran R and Pieters J: Regulation
of immune cell homeostasis and function by coronin 1. Int
Immunopharmacol. 28:825–828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sharma R, Kapila R, Dass G and Kapila S:
Improvement in Th1/Th2 immune homeostasis, antioxidative status and
resistance to pathogenic E. coli on consumption of probiotic
Lactobacillus rhamnosus fermented milk in aging mice. Age (Dordr).
36:96862014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Freeman GJ, Casasnovas JM, Umetsu DT and
DeKruyff RH: TIM genes: A family of cell surface phosphatidylserine
receptors that regulate innate and adaptive immunity. Immunol Rev.
235:172–189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang L, Ai Y and Tsung A: Clinical
application: Restoration of immune homeostasis by autophagy as a
potential therapeutic target in sepsis. Exp Ther Med. 11:1159–1167.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rossi M and Bot A: The Th17 cell
population and the immune homeostasis of the gastrointestinal
tract. Int Rev Immunol. 32:471–474. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Takeuchi Y and Nishikawa H: Roles of
regulatory T cells in cancer immunity. Int Immunol. 28:401–409.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cabrera R, Ararat M, Xu Y, Brusko T,
Wasserfall C, Atkinson MA, Chang LJ, Liu C and Nelson DR: Immune
modulation of effector CD4+ and regulatory T cell function by
sorafenib in patients with hepatocellular carcinoma. Cancer Immunol
Immunother. 62:737–746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu Y, Gao LF, Liang XH and Ma CH: Role of
Tim-3 in hepatitis B virus infection: An overview. World J
Gastroenterol. 22:2294–2303. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang L, Zhao C, Peng Q, Shi J and Gu G:
Expression levels of CD28, CTLA-4, PD-1 and Tim-3 as novel
indicators of T-cell immune function in patients with chronic
hepatitis B virus infection. Biomed Rep. 2:270–274. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cai C, Xu YF, Wu ZJ, Dong Q, Li MY, Olson
JC, Rabinowitz YM, Wang LH and Sun Y: Tim-3 expression represents
dysfunctional tumor infiltrating T cells in renal cell carcinoma.
World J Urol. 34:561–567. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
da Silva IP, Gallois A, Jimenez-Baranda S,
Khan S, Anderson AC, Kuchroo VK, Osman I and Bhardwaj N: Reversal
of NK-cell exhaustion in advanced melanoma by Tim-3 blockade.
Cancer Immunol Res. 2:410–422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cheng YQ, Ren JP, Zhao J, Wang JM, Zhou Y,
Li GY, Moorman JP and Yao ZQ: MicroRNA-155 regulates
interferon-gamma production in natural killer cells via Tim-3
signalling in chronic hepatitis C virus infection. Immunology.
145:485–497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fu X, Wu B, Huang B, Zheng H, Huang S, Gan
Y, Shen J, Lun ZR and Lu F: The correlation of Tim-3 and IFN-γ
expressions in mice infected with Toxoplasma gondii during
gestation. Parasitol Res. 114:125–132. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Charwat V, Rothbauer M, Tedde SF, Hayden
O, Bosch JJ, Muellner P, Hainberger R and Ertl P: Monitoring
dynamic interactions of tumor cells with tissue and immune cells in
a lab-on-a-chip. Anal Chem. 85:11471–11478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bose T and Trimper S: Noise-assisted
interactions of tumor and immune cells. Phys Rev E Stat Nonlin Soft
Matter Phys. 84:0219272011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Mazer B: Is there a place for B cells as
regulators of immune tolerance in allergic diseases? Clin Exp
Allergy. 44:469–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gao X, Yang J, He Y and Zhang J:
Quantitative assessment of TIM-3 polymorphisms and cancer risk in
Chinese Han population. Oncotarget. 7:35768–35775. 2016.PubMed/NCBI
|
